Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to approval will be clear as soon as the vaccine maker and the regulator agree on the ...

Novavax (NASDAQ:NVAX) shares climbed ~35% in the premarket on Thursday after the COVID-19 vaccine maker lifted its full-year ...

On a per-share basis, the Gaithersburg, Maryland-based company said it had net income of $2.93. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks ...